These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 17377972)

  • 1. Performance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial disease.
    Rocha-Singh KJ; Jaff MR; Crabtree TR; Bloch DA; Ansel G;
    Catheter Cardiovasc Interv; 2007 May; 69(6):910-9. PubMed ID: 17377972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-level meta-analysis of 999 claudicants undergoing primary femoropopliteal nitinol stent implantation.
    Rocha-Singh KJ; Beckman JA; Ansel G; Lyden SP; Schneider P; Mehta M; Dake M; Mullin CM; Jaff MR;
    Catheter Cardiovasc Interv; 2017 Jun; 89(7):1250-1256. PubMed ID: 28303688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease).
    Lammer J; Zeller T; Hausegger KA; Schaefer PJ; Gschwendtner M; Mueller-Huelsbeck S; Rand T; Funovics M; Wolf F; Rastan A; Gschwandtner M; Puchner S; Ristl R; Schoder M
    J Am Coll Cardiol; 2013 Oct; 62(15):1320-7. PubMed ID: 23831445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial clinical experience with the 4-F self-expanding XPERT stent system for infrapopliteal treatment of patients with severe claudication and critical limb ischemia.
    Kickuth R; Keo HH; Triller J; Ludwig K; Do DD
    J Vasc Interv Radiol; 2007 Jun; 18(6):703-8. PubMed ID: 17538131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of two different self-expanding nitinol stents for atherosclerotic femoropopliteal arterial disease (SENS-FP trial): study protocol for a randomized controlled trial.
    Park SH; Rha SW; Choi CU; Kim EJ; Oh DJ; Cho YH; Choi WG; Lee SJ; Kim YH; Choi SH; Kim WH; Kim KC; Cho JH; Kim JH; Kim SM; Bae JH; Bong JM; Kang WY; Baek JY; Seo JB; Chung WY; Park MW; Her SH; Suh J; Kim MW; Kim YJ; Choi HJ; Soh JW;
    Trials; 2014 Sep; 15():355. PubMed ID: 25208688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship Between Primary Patency and Lesion Length Following Bare Nitinol Stent Placement for Femoropopliteal Disease.
    Soga Y; Takahara M; Iida O; Suzuki K; Hirano K; Kawasaki D; Shintani Y; Yamaoka T; Ando K
    J Endovasc Ther; 2015 Dec; 22(6):862-7. PubMed ID: 26438352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary nitinol stenting for femoropopliteal disease.
    Mewissen MW
    J Endovasc Ther; 2009 Apr; 16(2 Suppl 2):II63-81. PubMed ID: 19624075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and clinical implications of stent fractures of the Xpert self-expanding nitinol stent in infrainguinal arteries.
    Keo HH; Kickuth R; Diehm N; Baumgartner I; Dai-Do D
    Vasa; 2009 Feb; 38(1):47-52. PubMed ID: 19229803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wire-Interwoven Nitinol Stent Outcome in the Superficial Femoral and Proximal Popliteal Arteries: Twelve-Month Results of the SUPERB Trial.
    Garcia L; Jaff MR; Metzger C; Sedillo G; Pershad A; Zidar F; Patlola R; Wilkins RG; Espinoza A; Iskander A; Khammar GS; Khatib Y; Beasley R; Makam S; Kovach R; Kamat S; Leon LR; Eaves WB; Popma JJ; Mauri L; Donohoe D; Base CC; Rosenfield K;
    Circ Cardiovasc Interv; 2015 May; 8(5):. PubMed ID: 25969545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-coated balloons to improve femoropopliteal artery patency: Rationale and design of the LEVANT 2 trial.
    Jaff MR; Rosenfield K; Scheinert D; Rocha-Singh K; Benenati J; Nehler M; White CJ
    Am Heart J; 2015 Apr; 169(4):479-85. PubMed ID: 25819854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitinol stent implantation in TASC A and B superficial femoral artery lesions: the Femoral Artery Conformexx Trial (FACT).
    Zeller T; Tiefenbacher C; Steinkamp HJ; Langhoff R; Wittenberg G; Schlüter M; Buergelin K; Rastan A; Krumsdorf U; Sixt S; Schulte CL; Tübler T; Krankenberg H
    J Endovasc Ther; 2008 Aug; 15(4):390-8. PubMed ID: 18729564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial.
    Duda SH; Bosiers M; Lammer J; Scheinert D; Zeller T; Oliva V; Tielbeek A; Anderson J; Wiesinger B; Tepe G; Lansky A; Jaff MR; Mudde C; Tielemans H; Beregi JP
    J Endovasc Ther; 2006 Dec; 13(6):701-10. PubMed ID: 17154704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angioplasty versus bare metal stenting for superficial femoral artery lesions.
    Chowdhury MM; McLain AD; Twine CP
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD006767. PubMed ID: 24959692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in self-expanding stents for use in the superficial femoral and popliteal arteries.
    Aghel A; Armstrong EJ
    Expert Rev Cardiovasc Ther; 2014 Jul; 12(7):833-42. PubMed ID: 24830846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the standard bolia technique versus subintimal recanalization plus Viabahn stent graft in the management of femoro-popliteal occlusions.
    Boufi M; Dona B; Orsini B; Auquier P; Hartung O; Alimi YS
    J Vasc Surg; 2010 Nov; 52(5):1211-7. PubMed ID: 20692789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Objective performance goals of safety and blood pressure efficacy for clinical trials of renal artery bare metal stents in hypertensive patients with atherosclerotic renal artery stenosis.
    Rocha-Singh KJ; Novack V; Pencina M; D'Agostino R; Ansel G; Rosenfield K; Jaff MR
    Catheter Cardiovasc Interv; 2011 Nov; 78(5):779-89. PubMed ID: 21648052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel-coated balloon or primary bare nitinol stent for revascularization of femoropopliteal artery: a meta-analysis of randomized trials versus uncoated balloon and an adjusted indirect comparison.
    Fusaro M; Cassese S; Ndrepepa G; King LA; Tada T; Ott I; Kastrati A
    Int J Cardiol; 2013 Oct; 168(4):4002-9. PubMed ID: 23890909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does endovascular treatment of infra-inguinal arterial disease with drug-eluting stents offer better results than angioplasty with or without bare metal stents?
    Antoniou GA; Georgakarakos EI; Antoniou SA; Georgiadis GS
    Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):282-5. PubMed ID: 24729201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary patency of femoropopliteal arteries treated with nitinol versus stainless steel self-expanding stents: propensity score-adjusted analysis.
    Sabeti S; Schillinger M; Amighi J; Sherif C; Mlekusch W; Ahmadi R; Minar E
    Radiology; 2004 Aug; 232(2):516-21. PubMed ID: 15286322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sirolimus for below the knee lesions: mid-term results of SiroBTK study.
    Commeau P; Barragan P; Roquebert PO
    Catheter Cardiovasc Interv; 2006 Nov; 68(5):793-8. PubMed ID: 17039538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.